Media

Dr. Audrey Halpern reviewed Nerivio on the Dr. Oz Show and explored the wearable neuromodulation options available to assist with migraine relief and prevention.

Several medical devices using electrical neuromodulation have been developed to treat pain, spinal injuries, epilepsy, migraine, and other conditions. More than just a new technological solution, the possibility presented by these devices is significant.

Theranica CEO Alon Ironi explains how his innovative technology, Nerivio, alleviates migraines and other ailments—all without the use of prescription drugs. Theranica is an Israeli biomedical technology company.

Evidence suggests that pharmacologic agents often used to treat migraine may at times be ineffective, poorly tolerated, contraindicated, and—if used too frequently—can cause possible medication overuse headache, migraine chronification, and notable medical complications. A significant unmet need exists for effective and well-tolerated non-pharmacologic acute migraine therapy, according to Alan M. Rapoport, MD.

Millions of Americans suffer from neurological disorders yearly, but progress is being made in managing neurological health and improving quality of life for patients. Through interviews and articles, this campaign raises awareness of neurological disorders including Alzheimer’s, Parkinson’s, epilepsy, migraine, and more. The campaign was distributed through USA TODAY and is published online

Theranica, the developer of Nerivio, has been ranked fourth in Fast Company's Biotech category on the 2020 Most Innovative Companies List. The prestigious annual list identifies companies making the most profound impact on their industry.

Migraineur Magazine chooses Nerivio for "Treatment of the Month". Choosing a drug-free therapy is a strong statement. Someone is putting patients first.

Good Morning America hosted a 3-day segment on migraine, in which Nerivio, one of Time’s best inventions in 2019, was highlighted as a solution for migraine relief.

Dr. William Young, a neurologist and headache specialist at Thomas Jefferson University Hospital in Philadelphia, talks about migraine and presents Nerivio on CBS This Morning.

Alon Ironi, Therania’s co-founder, CEO, and president, talks about Nerivio and the history behind its development.